C. Ludwig

A phase I/II study of rovalpituzumab tesirine in delta-like 3—expressing advanced solid tumors

H. Beltran, A. Mansfield, C. Chung, 2021, npj Precision Oncology.

A Phase 1 Study Evaluating Rovalpituzumab Tesirine in Frontline Treatment of Patients With Extensive-Stage SCLC

T. Burns, P. Ward, D. Camidge, 2021 .

35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts.

Thomas J. Smith, B. M. Rasmussen, V. C. Phan, 1999, Diabetologia.

A phase I/II study of rovalpituzumab tesirine in delta-like 3-expressing, advanced solid tumors.

H. Beltran, A. Mansfield, C. Chung, 2020 .

Brief Report: A Phase 1 Study Evaluating Rovalpituzumab Tesirine (Rova-T) in Frontline Treatment of Patients With Extensive-Stage Small Cell Lung Cancer.

T. Burns, P. Ward, D. Camidge, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Activity of Gemcitabine and Continuous Infusion Fluorouracil in Advanced Pancreatic Cancer

H. Friess, M. Büchler, C. Maurer, 2000, Oncology.